Notable Analyst Rating Changes 06/03: (BRCM) (HUN) (EWBC) Upgraded; (CLVS) (ZQK) (AGN) Downgraded

• CLSA from Outperform to Buy; and

• Wedbush from Neutral to Outperform while moving its price target from $30 up to $43. Click Here for more color.

Barclays raises East West Bancorp (Nasdaq: EWBC) from Equalweight to Overweight and moves its price target from $38 to $40.

Susquehanna moves WisdomTree Investments (Nasdaq: WETF) from Neutral to Positive.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES
Citi downgrades Clovis Oncology (Nasdaq: CLVS) from Buy to Neutral.

Stifel Nicolaus cuts Quiksilver (NYSE: ZQK) from Buy to Hold and removed its $9 price target.

Credit Suisse shops Allergen (NYSE: AGN) from Outperform to Neutral.

Susquehanna drops Oil States International (NYSE: OIS) from Positive to Neutral.

For daily real-time Downgrades go to http://www.streetinsider.com/downgrades

NEW COVERAGE
Jefferies assumes Applied Materials (Nasdaq: AMAT) at Buy and price target of $28. Click Here for more color.

Oppenheimer initiates SUPERVALU (NYSE: SVU) with an Outperform rating and a price target of $10.

MLV & Co. begins RAIT Financial Trust (NYSE: RAS) with a Buy rating and a price target of $10.

Aegis Capital starts Biocept (Nasdaq: BIOC) at Buy and price target of $16.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.